Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers. 1993

C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
Hôpital Pitié Salpêtrière, Service Pharmacie-Pharmacocinétique, Paris, France.

The disposition of the enantiomers of zopiclone and its two chiral metabolites was investigated after oral administration of a single dose of 15 mg of a racemic mixture (twice the usual therapeutic regimen) in 12 adult Caucasian volunteers. Determination of concentrations of zopiclone enantiomers in plasma showed that zopiclone pharmacokinetics is stereoselective with AUC0-->infinity values of 691.3 and 209.5 ng.ml-1.hr (p < 0.001), Cmax values of 87.3 and 44.0 ng.ml-1 (p < 0.001), oral CLtot/F values of 195.5 and 659.8 ml.min-1 (p < 0.001), Vd/F values of 98.6 and 192.8 liters (p < 0.01) and elimination half-life of 399.2 and 225.6 min (p < 0.01) for (+)-zopiclone and (-)-zopiclone, respectively. On the contrary, absorption half-life and Tmax values were not significantly different. In 48-hr urine, 3.6% of unchanged zopiclone was excreted, whereas 14.2% and 13.8% of both metabolites, N-desmethylzopiclone and N-oxidezopiclone, respectively, were found. Quantities of (+)-zopiclone excreted in urine were always higher compared with its antipode (-)-zopiclone for the 12 volunteers (p < 0.001). For the metabolites, quantities of both enantiomers were either equal or different and when different, it was always in favor of the (+)-enantiomer.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008297 Male Males
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D044465 White People Persons having origins in any of the white racial groups of Europe, the Middle East, or North Africa. Note that OMB category WHITE is available for the United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. European Continental Ancestry Group,White Person,Caucasian Race,Caucasoid Race,Caucasian Races,Caucasoid Races,People, White,Person, White,Race, Caucasian,Race, Caucasoid,White Peoples,White Persons
D053961 Azabicyclo Compounds Bicyclic bridged compounds that contain a nitrogen which has three bonds. The nomenclature indicates the number of atoms in each path around the rings, such as [2.2.2] for three equal length paths. Some members are TROPANES and BETA LACTAMS. Azabicyclo(1.1.0)Butanes,Azabicyclo(2.2.2)Octanes,Azabicyclo(3.3.1)Nonanes,Azabicyclo(4.3.0)Nonanes,Azabicyclo(5.2.2)Undecanes

Related Publications

C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
January 1997, European journal of clinical pharmacology,
C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
July 1998, International journal of clinical pharmacology and therapeutics,
C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
September 1993, Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao,
C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
November 2002, Antimicrobial agents and chemotherapy,
C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
November 1992, Journal of clinical pharmacology,
C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
August 1993, Journal of pharmaceutical sciences,
C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
October 1999, British journal of anaesthesia,
C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
June 1991, British journal of clinical pharmacology,
C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
September 2012, Basic & clinical pharmacology & toxicology,
C Fernandez, and V Maradeix, and F Gimenez, and A Thuillier, and R Farinotti
January 1995, Clinical pharmacokinetics,
Copied contents to your clipboard!